瑞财经 刘治颖近日，德镁医药有限公司（以下简称：德镁医药）赴港IPO获反馈意见。中国证监会国际司对德镁医药出具补充材料要求：一、请说明：（1）海南德镁收购广州禾零股权对价、定价依据、所得税缴纳情况，以及外商投资、税务等监管程序合法合规的结论性意见；（2）2025年4月股权转让所得税纳税情况；（3），以及相关外汇登记程序履行情况。二、请说明：（1）海南德镁医药科技、上海德镁馨医药实际业务经营情况，...
Source Link瑞财经 刘治颖近日，德镁医药有限公司（以下简称：德镁医药）赴港IPO获反馈意见。中国证监会国际司对德镁医药出具补充材料要求：一、请说明：（1）海南德镁收购广州禾零股权对价、定价依据、所得税缴纳情况，以及外商投资、税务等监管程序合法合规的结论性意见；（2）2025年4月股权转让所得税纳税情况；（3），以及相关外汇登记程序履行情况。二、请说明：（1）海南德镁医药科技、上海德镁馨医药实际业务经营情况，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.